Chemicalinfo Chemlink Pharm-Chem Net

Chemical Pharmaceutical News

All About Lung Cancer

All About Lung CancerDescription of Lung CancerLung cancer is the number one cause of cancer deaths among men and women in the United States. There are two major types of lung cancer: small cell and non-small cell. Non-small cell makes up about 80 to...

DSM and MorphoSys add MOR202 to Ab deal

DSM and MorphoSys add MOR202 to Ab dealBy Gareth Macdonald14-Aug-2008 - US-based DSM Biologics and MorphoSys are teaming up to manufacture the MOR202 antibody, which has shown considerable promise as a treatment for multiple myeloma (MM).The agent, w...

Siemens building radiopharma sites in India

Siemens building radiopharma sites in IndiaBy Nick Taylor13-Aug-2008 - Siemens has outlined plans to establish itself as a leading provider of radiopharmaceuticals in India through the construction of numerous manufacturing facilities.The company has...

Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS)

Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS)This study has been completed. Sponsored by: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ...

Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older

Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and OlderThis study has been completed. Sponsored by: Johnson & Johnson Pharmaceutical Research & Development...

Cancer drugs postcode lottery

Cancer drugs 'postcode lottery'SARAH BREALEY11 August 2008 17:15Access to the latest cancer drugs is a postcode lottery, according to research from a charity.In some areas of the country, every exceptional request for a cancer drug which is not u...

Ramelteon: A Novel Approach in the Treatment of Insomnia

ARTICLES Ramelteon: A Novel Approach in the Treatment of Insomnia (CE) (September) Jill N Reynoldson PharmD1, Ellie SR Elliott PharmD BCPP2, Leigh Anne Nelson PharmD BCPP3* 1 Psychi...

多靶点抗肿瘤酪氨酸激酶抑制剂

多靶点抗肿瘤酪氨酸激酶抑制剂 中国医学科学院肿瘤医院     孙燕 王燕 周爱萍 李勇     近年来,随着分子生物学技术的进展和从细胞受体与增殖调控的分子水平对肿瘤发病机制认识的进一步深入,针对细胞受体、关键基因和调...

Gilead Sciences and Merck & Co., Inc. Enter Into an Agreement to Register and Distribute HIV Medication Atripla® (Efavirenz 600 mg/ Emtricitabine 200 mg/ Tenofovir Disoproxil Fumarate 300 mg) in Twelve Countries

Gilead Sciences and Merck & Co., Inc. Enter Into an Agreement to Register and Distribute HIV Medication Atripla® (Efavirenz 600 mg/ Emtricitabine 200 mg/ Tenofovir Disoproxil Fumarate 300 mg) in Twelve Countries

Sprycel (Dasatinib) Effective for CNS Philadelphia Chromosome-positive Leukemia

Cancer News Article ord=Math.random()*10000000000000000;document.write('');Sprycel® Effective for CNS Philadelphia Chromosome-...
分页:[«][1][2][3]4[5][6][7][8][9][»]

Powered By Z-Blog 1.7 Laputa Build 70216

Copyright 2005-2009 Your WebSite. Some Rights Reserved.